Adverse COVID-19 vaccination effects in Finnish patients with Meniere's disease : a cross-sectional study

dc.contributor.authorBeukes, Eldre W.
dc.contributor.authorManchaiah, Vinaya
dc.contributor.authorPyykko, Nora
dc.contributor.authorPyykko, Ilmari
dc.date.accessioned2023-06-27T05:51:17Z
dc.date.available2023-06-27T05:51:17Z
dc.date.issued2022-08-04
dc.descriptionDATA AVAILABILITY : UNDERLYING DATA : Figshare: COVID 19 vaccine in Ménière’s disease, https://doi.org/10.6084/m9.figshare.19519801. This project contains the following underlying data: - COVID vaccine in MD for repository.xslx (raw data). EXTENDED DATA : Figshare: COVID 19 vaccine in Ménière’s disease, https://doi.org/10.6084/m9.figshare.19519801. This project contains the following extended data: - Finnish_MD COVID Vaccination Questionnaire - English_MD COVID Vaccination Questionnaire - S 1S1 The STROBE Checklist. Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).en_US
dc.description.abstractBACKGROUND : The association between reporting adverse coronavirus disease 2019 (COVID-19) vaccination effects and those with a history of audiovestibular difficulties is unknown. The aim of this research is therefore to investigate adverse vaccination effects in adults with a history of Ménière’s disease. Specifically, the incidence of adverse effects, the factors associated with those reporting adverse effects and the relationship between the reporting of audiovestibular and other adverse effects. METHODS : A mixed-methods exploratory cross-sectional survey study design was used. Data were collected from 333 members of the Finnish Ménière Association. The survey was designed to obtain demographic information that may be associated with having adverse effects or not, vaccination-specific information and adverse vaccination effects. Both health and audiovestibular adverse events were identified. Data analysis included comparing those reporting and not reporting adverse vaccination effects. RESULTS : The mean age was 63 years with 81% being female. Of the 327 respondents who had one of the COVID-19 vaccinations (Comirnatry/ Pfizer, Astra Zeneca, or Moderna), 203 (62%) reported no adverse effects. The type of or number of vaccinations were not related to the reporting of adverse effects. The most frequently reported adverse effects were injection site tenderness (38%), arm pain (21%), fever (15%) and headaches (15%). Post-vaccination tinnitus and vertigo (both 7%) were the most frequently reported audiovestibular-related symptoms, followed by aural fullness (6%) and hearing loss (4%). Those reporting previous pre-vaccination vertigo were more likely to have post-vaccination vertigo. The presence of post-vaccination tinnitus, hearing loss, and aural fullness, predicted the presence of post-vaccination vertigo. CONCLUSIONS : A small proportion of patients with a history of Ménière’s disease may experience adverse post-vaccination effects. Further research is required to explore whether adverse postvaccination audiovestibular effects are more prevalent in those with a history of otological disorders compared with the general population.en_US
dc.description.departmentSpeech-Language Pathology and Audiologyen_US
dc.description.librarianam2023en_US
dc.description.urihttp://f1000research.comen_US
dc.identifier.citationBeukes, E., Manchaiah. V., Pyykkö, N. and Pyykkö, I. Adverse COVID-19 vaccination effects in Finnish patients with Ménière’s disease: a cross-sectional study. F1000Research 2022, 11:893 https://DOI.org/10.12688/f1000research.113143.1.en_US
dc.identifier.issn2046-1402
dc.identifier.other10.12688/f1000research.113143.1
dc.identifier.urihttp://hdl.handle.net/2263/91208
dc.language.isoenen_US
dc.publisherF1000 Research Ltden_US
dc.rights© 2022 Beukes E et al. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License.en_US
dc.subjectMeniere’s diseaseen_US
dc.subjectAudiovestibularen_US
dc.subjectVertigoen_US
dc.subjectHearing lossen_US
dc.subjectTinnitusen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectVaccinationen_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleAdverse COVID-19 vaccination effects in Finnish patients with Meniere's disease : a cross-sectional studyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Beukes_Adverse_2022.pdf
Size:
670.72 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: